Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

25.81
+0.60002.38%
Post-market: 25.50-0.3100-1.20%19:43 EDT
Volume:1.87M
Turnover:47.89M
Market Cap:2.54B
PE:-4.43
High:25.85
Open:25.22
Low:25.11
Close:25.21
52wk High:39.89
52wk Low:18.29
Shares:98.32M
Float Shares:80.72M
Volume Ratio:0.92
T/O Rate:2.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-8.72
PE(LYR):-4.43

Loading ...

Ultragenyx announces publication of Phase 3 Genglycos trial results

TIPRANKS
·
6 hours ago

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of Genglycos™ (Also Known as Dtx401) Aav Gene Therapy in Gsdia in the Journal of Inherited Metabolic Disease

THOMSON REUTERS
·
7 hours ago

Ultragenyx Grants 45,984 Inducement RSUs to 23 New Hires

Reuters
·
Aug 26

Ultragenyx Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 26

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 26

Ultragenyx Pharma Price Target Raised to $80.00/Share from $75.00 by JP Morgan

Dow Jones
·
Aug 25

Ultragenyx Pharmaceutical Inc. : Morgan Stanley Raises Target Price to $74 from $67

THOMSON REUTERS
·
Aug 21

Analysts’ Top Healthcare Picks: Evaxion Biotech (EVAX), Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Aug 21

U.S. Stocks on the MOVE-Apple, Hims & Hers Health, Sysco

Reuters
·
Aug 20

Ultragenyx Pharmaceutical (RARE) Stock Jumps 9% on Accelerated FDA Approval

TIPRANKS
·
Aug 20

Sector Update: Healthcare

MT Newswires Live
·
Aug 20

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Ultragenyx Pharmaceutical (RARE) and Cytokinetics (CYTK)

TIPRANKS
·
Aug 20

Cantor Fitzgerald Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Aug 20

U.S. Stocks on the MOVE-Walmart, Atour Lifestyle, Wolfspeed

Reuters
·
Aug 20

Ultragenyx Pharmaceutical Shares up 8.6% Premarket After Securing FDA Nod for Rare Metabolic Disorder Gene Therapy

THOMSON REUTERS
·
Aug 20

Ultragenyx price target raised to $83 from $81 at Canaccord

TIPRANKS
·
Aug 20

Ultragenyx Pharma Price Target Raised to $103.00/Share from $96.00 by Cantor Fitzgerald

Dow Jones
·
Aug 20

Ultragenyx price target raised to $58 from $45 at Citi

TIPRANKS
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Ultragenyx Pharmaceutical (RARE) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Aug 20